Anti-CD20 treatment depletes B-cells in blood and lymphatic tissue of cynomolgus monkeys
- 30 November 2003
- journal article
- Published by Elsevier in Transplant Immunology
- Vol. 12 (1) , 19-28
- https://doi.org/10.1016/s0966-3274(03)00059-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome1Transplantation, 2003
- Tolerance induction in rats, using a combination of anti-CD154 and donor splenocytes, given once on the day of transplantation1Transplantation, 2003
- B-cell development in the thymus is limited by inhibitory signals from the thymic microenvironmentBlood, 2002
- An open study of B lymphocyte depletion in systemic lupus erythematosusArthritis & Rheumatism, 2002
- B cell–ablative therapy for the treatment of autoimmune diseasesArthritis & Rheumatism, 2002
- Clearance of erythrocyte allo-antibodies using RituximabBone Marrow Transplantation, 2002
- Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa geneBlood, 2002
- Effective B Cell Depletion with Rituximab in the Treatment of Autoimmune DiseasesImmunobiology, 2002
- Effects of specific anti‐B and/or anti‐plasma cell immunotherapy on antibody production in baboons: depletion of CD20‐ and CD22‐positive B cells does not result in significantly decreased production of anti‐αGal antibodyXenotransplantation, 2001
- THE ASSOCIATION OF ENHANCEMENT OF RENAL ALLOGRAFT SURVIVAL BY DONOR-SPECIFIC BLOOD TRANSFUSION WITH HOST MHC-LINKED INHIBITION OF IgG ANTI-DONOR CLASS I ALLOANTIBODY RESPONSESTransplantation, 1993